Active, not recruitingPhase 2

A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease

NCT02726386

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Xenoscience

Phoenix, Arizona, United States

+56 additional locations

View on ClinicalTrials.gov

Save this trial

Quick facts

Start date: 2016-05-04
Enrollment: 214 participants
Sponsor: NeuroDerm Ltd.
Purpose: treatment

Locations (57)

XenosciencePhoenix, Arizona, United States
Clinical Trials Inc.Little Rock, Arkansas, United States
The Parkinsons and Movement Disorder InstituteFountain Valley, California, United States
Neuro Pain Medical CenterFresno, California, United States
University of Colorado DenverAurora, Colorado, United States
Rocky Mountain Movement Disorders CenterEnglewood, Colorado, United States
Parkinson's Disease and Movement Disorder Center of Boca RatonBoca Raton, Florida, United States
MD ClinicalHallandale, Florida, United States
Infinity Clinical Research, LLCHollywood, Florida, United States
University of Florida Health at JacksonvilleJacksonville, Florida, United States
Neurology Associates, PAMaitland, Florida, United States
Parkinsons Disease Treatment Center of Southwest FloridaPort Charlotte, Florida, United States
Suncoast Neuroscience AssociatesSt. Petersburg, Florida, United States
Infinity Clinical Research, LLCSunrise, Florida, United States
USF Health Parkinson's Disease and Movement DisordersTampa, Florida, United States
Northwestern UniversityChicago, Illinois, United States
Unity Point HealthDes Moines, Iowa, United States
University of Maryland, NeurologyBaltimore, Maryland, United States
QUEST Research InstituteFarmington Hills, Michigan, United States
Henry Ford HospitalWest Bloomfield, Michigan, United States
Pyramid Clinical ResearchSomerset, New Jersey, United States
University of CincinnatiCincinnati, Ohio, United States
The Movement Disorder Clinic of OklahomaTulsa, Oklahoma, United States
Synergy TrialsRichmond, Virginia, United States
Sentara Neuroscience InstituteVirginia Beach, Virginia, United States
Premier ResearchSpokane, Washington, United States
Medical University InnsbruckInnsbruck, Austria
NEUROHK, s.r.o.Choceň, Czechia
Clintrial s.r.o.Prague, Czechia
Vestra Clinics, s.r.o.Rychnov nad Kněžnou, Czechia
Centre Hospitalier d'AixAix-en-Provence, France
CHU d'Amiens, Hopital SudAmiens, France
Hopital Neurologique Pierre WertheimerBron, France
Hôpital Gabriel MontpiedClermont-Ferrand, France
Hopital Roger SalengroLille, France
Hopital de la TimoneMarseille, France
CHU de PoitiersPoitiers, France
Kliniken Beelitz GmbHBeelitz-Heilstätten, Germany
St. Josefs HospitalBochum, Germany
Klinikum-Bremerhaven ReinkenheideBremerhaven, Germany
Universitaetsklinikum Carl Gustav Carus an der Technischen Universitaet DresdenDresden, Germany
Klinik HaagHaag in Oberbayern, Germany
Universitaets-und Rehabilitationskliniken UlmUlm, Germany
Barzilai MCAshkelon, Israel
Hadassah Medical Center, Ein-Kerem CampusJerusalem, Israel
Rabin Medical CenterPetah Tikva, Israel
Chaim Sheba Medical CenterRamat Gan, Israel
Sourasky Medical CenterTel Aviv, Israel
University FoundationChieti, Italy
AOU PisaPisa, Italy
IRCCS San Raffaele PisanaRome, Italy
IRCCS Hospital San Camillo VeniceVenice, Italy
Centrum Medyczne PLEJADYKrakow, Poland
Krakowska Akademia Neurologii Sp. z o.o.Krakow, Poland
Indywidualna Praktyka Lekarska prof. dr habLublin, Poland
Hospital Clinic de BarcelonaBarcelona, Spain
Hospital Universitario de la PrincesaMadrid, Spain